Trademark Overview
On Friday, November 14, 2025, a trademark application was filed for CODIS with the United States Patent and Trademark Office. The USPTO has given the CODIS trademark a serial number of 99496902. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, July 2, 2026. This trademark is owned by Particle Dynamics Holdings, Inc. The CODIS trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical research and development; contract development services for pharmaceuticals; Pharmaceutical research and development in the nature of pharmaceutical product design and optimization; Pharmaceutical research and development in the nature of analytical testing of pharmaceuticals; Pharmaceutical research and development in the nature of stability testing; Pharmaceutical research and development in the nature of method development and validation; Pharmaceutical research and development in the nature of technology transfer in the field of pharmaceuticals; consulting services in the field of drug development and manufacturing
Contract pharmaceutical manufacturing services in the field of pharmaceuticals; custom synthesis of active pharmaceutical ingredients (APIs); formulation of pharmaceutical preparations for others; Contract pharmaceutical manufacturing services in the nature of pharmaceutical spray drying services; Contract pharmaceutical manufacturing services in the nature of solvent spray drying services; Contract pharmaceutical manufacturing services in the nature of pharmaceutical tableting, encapsulation, and blending services; Contract pharmaceutical manufacturing services in the nature of packaging services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of labeling services for pharmaceuticals; Contract pharmaceutical manufacturing services in the nature of processing of pharmaceutical intermediates; scale-up and commercial manufacturing of pharmaceutical products for others; consulting services in the field of manufacturing
Dietary and nutritional supplements; active pharmaceutical ingredients (APIs), namely, Sevelamer Carbonate and Sevelamer Hydrochloride; drug delivery systems in the form of amorphous solid dispersions that facilitate the delivery of pharmaceutical preparations; spray-dried pharmaceutical products for treatment of hyperphosphatemia
Magnesium carbonate; Particulate precursor components in the nature of chemical additives for use in the manufacture of pharmaceutical tablets and nutritional and dietary supplements; chemicals sold in bulk for use in the manufacturing, processing and packing of nutritional supplements, vitamins, and pharmaceutical products and preparations; chemical encased in a matrix which is sold in bulk for manufacturing, processing or repacking of chemicals; Chemical tastemasking additives, stability and flavor enhancers, for use in the manufacture of pharmaceuticals, namely, antihistamines, anti-nausea agents, neonatal agents, osteoporetic, nutraceuticals, and pharmaceuticals, namely, hormones, anti-infectives, and fertility agents; Excipients for use in the manufacture of pharmaceuticals
